To qualify for GLP-1 medications at top providers in 2026, patients generally require a BMI of 30 or greater, or a BMI of 27 with at least one weight-related condition such as hypertension.
Mandatory Requirements
Body Mass Index of 30+ or 27+ with a comorbidity.
Screening and prescription from a licensed healthcare provider.
Lab work or blood panels to confirm metabolic status and safety.
Policy & Intake Updates
A comprehensive 2026 review highlights the best clinical sources for GLP-1 therapies, emphasizing providers that help navigate insurance and medical eligibility requirements.
View Source Verification →